BMI and health risk
There is a large body of evidence to suggest that excess body weight as measured by BMI can have a number of harmful health effects, such as increasing risk of cardiovascular disease, type 2 diabetes, and mortality (1-8). However, BMI’s usefulness in predicting health risk beyond that of waist circumference alone is unclear (2, 3, 7-11). Though some studies have reported that BMI can help identify individuals at increased health and mortality risk beyond that of waist circumference alone (2, 3, 7, 8), others have not (2, 9-11).
Health-related BMI cut-offs
Health Canada and the National Institutes of Health (NIH) in the United States have developed BMI categories for classifying underweight, normal weight, overweight, and obesity in Caucasians (Table) (12, 13). These cut-offs appear to be appropriate for non-Hispanic blacks, but are likely too high for some Asian populations (8, 14-16). Appropriate BMI cut-offs for Asian populations are not as well established, but the suggested values for overweight range from 22 to 27 kg/m2 and 26 to 31 kg/m2 for obesity (14). These Asian cut-offs were based on the relationship between BMI and total adiposity in Asian versus Caucasian populations and did not consider the relationship of BMI to morbidity or mortality. Asians have more body fat than Caucasians for a given BMI, and the lower proposed BMI cut-offs for Asians reflect BMI values associated with the same percent body fat indicating overweight and obesity in Caucasian populations (14). For example, a BMI of 25 kg/m2 in Caucasian populations generally means 22% body fat in men and 35% body fat in women. In contrast, individuals from Singapore will have this degree of body fatness with a BMI of only 22 kg/m2. Some Asian populations also appears to be at increased health risk at lower BMI values compared to Caucasians. However, it is currently unclear whether ethnicity alters the association between BMI and health risk enough to warrant multiple population-specific BMI cut-offs.

Role of the Dysregulated Endocannabinoid System in Determining Cardiometabolic Risk by Vincenzo Di Marzo, PhD
More
What is the role of low HDL cholesterol in the elevated CHD risk of metabolic syndrome patients? By Philip J. Barter, MBBS, FRACP, PhD
More
Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes (Lond) 2008;32:283-91
More
Schematic representation of how smoking might add to several mechanisms linking obesity to cardiovascular disease
More